CR11759A - Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas - Google Patents
Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativasInfo
- Publication number
- CR11759A CR11759A CR11759A CR11759A CR11759A CR 11759 A CR11759 A CR 11759A CR 11759 A CR11759 A CR 11759A CR 11759 A CR11759 A CR 11759A CR 11759 A CR11759 A CR 11759A
- Authority
- CR
- Costa Rica
- Prior art keywords
- espiro
- piperidines
- treatment
- neurodegenerative diseases
- new class
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Se desvelan compuestos y sales farmaceuticamente aceptables de los compuestos, teniendo los compuestos la estructura de la formula I, como se define en la memoria descriptiva.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5042308P | 2008-05-05 | 2008-05-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR11759A true CR11759A (es) | 2010-11-22 |
Family
ID=40902870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR11759A CR11759A (es) | 2008-05-05 | 2010-10-26 | Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas |
Country Status (22)
Country | Link |
---|---|
US (1) | US20110046160A1 (es) |
EP (1) | EP2300484B1 (es) |
JP (1) | JP2011519913A (es) |
KR (1) | KR20110000749A (es) |
CN (1) | CN102083841A (es) |
AP (1) | AP2010005456A0 (es) |
AT (1) | ATE537178T1 (es) |
AU (1) | AU2009245322B2 (es) |
BR (1) | BRPI0912433A2 (es) |
CA (1) | CA2721786A1 (es) |
CO (1) | CO6321280A2 (es) |
CR (1) | CR11759A (es) |
DO (1) | DOP2010000317A (es) |
EA (1) | EA201001566A1 (es) |
EC (1) | ECSP10010597A (es) |
ES (1) | ES2375913T3 (es) |
IL (1) | IL208793A0 (es) |
MA (1) | MA32290B1 (es) |
MX (1) | MX2010012066A (es) |
NZ (1) | NZ588589A (es) |
SV (1) | SV2010003725A (es) |
WO (1) | WO2009136350A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
UA108363C2 (uk) | 2009-10-08 | 2015-04-27 | Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування | |
JP2013523806A (ja) * | 2010-04-09 | 2013-06-17 | ファイザー・インク | スルタム化合物 |
EP2694521B1 (en) | 2011-04-07 | 2015-11-25 | Merck Sharp & Dohme Corp. | Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
EP2694489B1 (en) | 2011-04-07 | 2017-09-06 | Merck Sharp & Dohme Corp. | C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
JP2014524472A (ja) | 2011-08-22 | 2014-09-22 | メルク・シャープ・アンド・ドーム・コーポレーション | Bace阻害剤としての2−スピロ置換イミノチアジンならびにそのモノオキシドおよびジオキシド、組成物、ならびにそれらの使用 |
US10752588B2 (en) | 2014-12-19 | 2020-08-25 | The Broad Institute, Inc. | Dopamine D2 receptor ligands |
EP3233077A4 (en) | 2014-12-19 | 2018-08-08 | The Broad Institute Inc. | Dopamine d2 receptor ligands |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005068463A1 (en) * | 2004-01-08 | 2005-07-28 | F. Hoffmann-La Roche Ag | Diaza-spiropiperidine derivatives |
JP2006044497A (ja) * | 2004-08-05 | 2006-02-16 | Toyota Motor Corp | 車輪情報処理装置 |
AU2005295814A1 (en) * | 2004-10-13 | 2006-04-27 | Merck & Co., Inc. | Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of Alzhermer's disease |
ATE550338T1 (de) * | 2005-07-18 | 2012-04-15 | Merck Sharp & Dohme | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit |
EP2063889A4 (en) * | 2006-09-07 | 2009-09-16 | Merck & Co Inc | SPIROPIPERIDINE BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER DISEASE |
WO2008085509A1 (en) * | 2007-01-04 | 2008-07-17 | Merck & Co., Inc. | Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
-
2009
- 2009-05-04 JP JP2011508035A patent/JP2011519913A/ja not_active Withdrawn
- 2009-05-04 EA EA201001566A patent/EA201001566A1/ru unknown
- 2009-05-04 CA CA2721786A patent/CA2721786A1/en not_active Abandoned
- 2009-05-04 AU AU2009245322A patent/AU2009245322B2/en not_active Ceased
- 2009-05-04 AT AT09742523T patent/ATE537178T1/de active
- 2009-05-04 MX MX2010012066A patent/MX2010012066A/es not_active Application Discontinuation
- 2009-05-04 AP AP2010005456A patent/AP2010005456A0/xx unknown
- 2009-05-04 BR BRPI0912433A patent/BRPI0912433A2/pt not_active Application Discontinuation
- 2009-05-04 US US12/990,739 patent/US20110046160A1/en not_active Abandoned
- 2009-05-04 EP EP09742523A patent/EP2300484B1/en active Active
- 2009-05-04 CN CN2009801261947A patent/CN102083841A/zh active Pending
- 2009-05-04 NZ NZ588589A patent/NZ588589A/en not_active IP Right Cessation
- 2009-05-04 KR KR1020107024794A patent/KR20110000749A/ko not_active Application Discontinuation
- 2009-05-04 WO PCT/IB2009/051815 patent/WO2009136350A1/en active Application Filing
- 2009-05-04 ES ES09742523T patent/ES2375913T3/es active Active
-
2010
- 2010-10-18 IL IL208793A patent/IL208793A0/en unknown
- 2010-10-21 DO DO2010000317A patent/DOP2010000317A/es unknown
- 2010-10-26 CR CR11759A patent/CR11759A/es not_active Application Discontinuation
- 2010-11-05 MA MA33328A patent/MA32290B1/fr unknown
- 2010-11-05 SV SV2010003725A patent/SV2010003725A/es not_active Application Discontinuation
- 2010-11-09 EC EC2010010597A patent/ECSP10010597A/es unknown
- 2010-11-11 CO CO10141834A patent/CO6321280A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL208793A0 (en) | 2010-12-30 |
BRPI0912433A2 (pt) | 2015-12-22 |
EA201001566A1 (ru) | 2011-04-29 |
EP2300484B1 (en) | 2011-12-14 |
ECSP10010597A (es) | 2010-12-30 |
WO2009136350A1 (en) | 2009-11-12 |
AU2009245322A1 (en) | 2009-11-12 |
ES2375913T3 (es) | 2012-03-07 |
NZ588589A (en) | 2012-07-27 |
MA32290B1 (fr) | 2011-05-02 |
JP2011519913A (ja) | 2011-07-14 |
EP2300484A1 (en) | 2011-03-30 |
CA2721786A1 (en) | 2009-11-12 |
US20110046160A1 (en) | 2011-02-24 |
KR20110000749A (ko) | 2011-01-05 |
SV2010003725A (es) | 2011-07-05 |
CN102083841A (zh) | 2011-06-01 |
CO6321280A2 (es) | 2011-09-20 |
ATE537178T1 (de) | 2011-12-15 |
DOP2010000317A (es) | 2010-11-15 |
AP2010005456A0 (en) | 2010-12-31 |
AU2009245322B2 (en) | 2011-07-14 |
MX2010012066A (es) | 2010-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY30500A1 (es) | Compuestos de azabencimidazolilo | |
CR11759A (es) | Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas | |
UY31189A1 (es) | Compuestos heterocíclicos | |
CU20150062A7 (es) | Lactamas n-(heteroarilo sustituido) fusionadas utiles en el tratamiento del crecimiento celular anormal | |
CY1118662T1 (el) | Νεες δικυκλικες πυριδινονες | |
CR20140399A (es) | Pirrolidina-2-carboxamidas sustituidas | |
PE20151788A1 (es) | Inhibidores de bromodominios tetraciclicos | |
ECSP12012083A (es) | Pirrolidina-2-carboxamidas sustituidas | |
ECSP13012611A (es) | Derivados de pirazol-aminopirimidina como moduladores de la lrrk2 | |
PE20151023A1 (es) | Triazolopirazinas | |
CO6361910A2 (es) | Pirrolidina-2-carboxamidas sustituidas | |
UY32977A (es) | Novedosos compuestos como inhibidores de la caseina quinasa | |
HN2012001413A (es) | Derivados de pirazina y su uso en el tratamiento de trastornos neurólogicos | |
CY1117745T1 (el) | Ετεροκυκλικες ενωσεις και χρηση αυτων ως ρυθμιστες υποδοχεα τυπου iii κινασων τυροσινης | |
CU24087B1 (es) | Compuestos de carbazol | |
NI201100096A (es) | Lactamas como inhibidores de beta secretasa. | |
CO6491060A2 (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
GT201200138A (es) | Derivados de sulfonamida heterocíclicos útiles como inhibidores de mek | |
CU20130139A7 (es) | Derivados glocósidos y usos de los mismos | |
CU20110088A7 (es) | Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales | |
CU20110233A7 (es) | Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas | |
UY34043A (es) | Isoxazolinas como agentes terapéuticos | |
ECSP11011217A (es) | Microbiocidas nuevos. | |
UY31775A (es) | Compuestos heterocíclicos como inhibidores de mek | |
CR20150148A (es) | Azaindolinas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |